Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Exercise or conversion Director acquired 39,506 shares (option exercise)
  15. 4 Open-market buy Director bought 58,357 shares at an average $2.37 ($138,225)
  16. 4 Open-market buy Director bought 40,215 shares at an average $2.37 ($95,355)
  17. 4 Open-market sale Director sold 25,000 shares at an average $11.10 ($277,622)
  18. 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $10.79 ($80,926)
  19. 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $9.02 ($67,675)
  20. 4 Open-market sale President and COO sold 25,000 shares at an average $9.03 ($225,665)

Page 9 of 22 · 436 filings